OssDsign Investor Relations Material
Latest events
Q4 2024
OssDsign
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from OssDsign
Access all reports
Segment Data
Access more data
Revenue by
Geography
U.S.
Germany
Rest of Europe
U.K.
Other
Expenses by
Financials
OssDsign AB designs, manufactures, and sells implants and material technology for bone regeneration. The company's products are used to treat bone defects in the hard palate and other areas as well as to support dental implants. The company has strategic relations with several companies across Europe and the US, and markets their products to customers all over the world. OssDsign's aim is to be an innovative and leading specialty pharma player within the fast growing bone reconstruction market by providing products that offer unique opportunities for superior clinical outcomes, thereby adding value for patients, healthcare providers and investors.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
OSSD
Country
🇸🇪 Sweden